Owensboro Health Regional Hospital received designation as a Care Continuum Center of Excellence by the GO2 Foundation for Lung Cancer. The designation recognizes commitment to improving outcomes for those diagnosed with lung cancer by providing patient-focused and coordinated multidisciplinary care.
GO2 Foundation has formed the Care Continuum Centers of Excellence program to enable patient access to standard of care lung cancer screening, early detection, diagnosis, treatment and survivorship in their local community.
“We are proud and honored to be working with Owensboro Health Regional Hospital as a GO2 Foundation Care Continuum Center of Excellence,” said Laurie Fenton Ambrose — Co-Founder, President and CEO of GO2 Foundation. “Their commitment will help save lives and improve long-term survivorship by giving patients access to high-quality, multidisciplinary care closer to home. They are the example to follow.”
The Care Continuum Centers of Excellence (CCCOE) program recognizes community hospitals that meet rigorous qualifying criteria that demonstrate collaborative leadership across the lung cancer care continuum.
Meeting the CCCOE criteria puts member hospitals on par with leading academic and research institutions and provides patients with access to the latest innovations not typically found in community hospitals. The CCCOE approach results in patients receiving compassionate and timely care, as well as treatment options that improve survivorship.
“Lung cancer affects many families that are served by Owensboro Health. Lung cancer also leads in cancer-related deaths, exacting a heavy toll on our community,” said Dr. Michael Muzoora of Owensboro Health Pulmonology. “Practicing at a health care system that makes every effort to provide state-of-the-art care to patients and families navigating cancer treatment is encouraging. We look forward to the GO2 partnership as we continue to improve on the care and support offered to our community.”
Owensboro Health Regional Hospital received the Center of Excellence in Lung Cancer Screening designation in 2019, and this year’s overall CCCOE designation demonstrates a continued commitment to improving care for patients with lung cancer in the region.